ArticleOncoTargets and therapy2016

Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer.

Yan-Wei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.